Top compounds associated with response to MRPL39


Feature Type Standardized
Nominal ANOVA
mRNA temsirolimus GDSC1000 pan-cancer AAC 0.1 0.004
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.004
mRNA Gemcitabine GDSC1000 pan-cancer AAC 0.11 0.004
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.004
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.005
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.005
mRNA BMS-754807 GDSC1000 pan-cancer AAC -0.1 0.005
mRNA TAE684 GDSC1000 pan-cancer AAC -0.16 0.006
mRNA Camptothecin GDSC1000 pan-cancer AAC 0.098 0.006
mRNA OSI-930 CTRPv2 pan-cancer AAC 0.1 0.006
Download CSV